Neurotoxicity of advanced glycation end-products for cultured cortical neurons. - Wikidata - wikimedia - TriplyDB

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

http://www.wikidata.org/entity/Q33181556

about

Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice The sour side of neurodegenerative disorders: the effects of protein glycation.D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation.Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitro SOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cells Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD D-ribose induces cellular protein glycation and impairs mouse spatial cognition.Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism.Involvement of Maillard reactions in Alzheimer disease.In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats Role of advanced glycation end products and their receptors in development of diabetic neuropathy.The ligand/RAGE axis: lighting the fuse and igniting vascular stress.Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.Effect of Amaranthus on Advanced Glycation End-Products Induced Cytotoxicity and Proinflammatory Cytokine Gene Expression in SH-SY5Y Cells.Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants.Neuropathy induced by exogenously administered advanced glycation end-products in rats.MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells.The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum.Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.Detection and determination of glyceraldehyde-derived advanced glycation end product.Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.Advanced glycation end products induce endothelial-to-mesenchymal transition via downregulating Sirt 1 and upregulating TGF-β in human endothelial cells.Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies.Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products Immunological detection of fructose-derived advanced glycation end-products.Chemistry and biological effects of melanoidins and glyceraldehyde-derived pyridinium as advanced glycation end products.Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.Formation mechanisms of melanoidins and fluorescent pyridinium compounds as advanced glycation end products.Cytotoxicity of acetaldehyde-derived advanced glycation end-products (AA-AGE) in alcoholic-induced neuronal degeneration.Receptor for advanced glycation end products (RAGE)-mediated cytotoxicity of 3-hydroxypyridinium derivatives.

P2860

Q22306304-D5C6B9F6-A840-4F97-A9DF-014A483EED0A Q26747425-1D180773-3134-499E-9778-63C78668BD4E Q27340344-7E5A2068-2338-415A-9961-E77B5CAC8C11 Q30386079-8FF6642C-7311-4D36-9370-0ECBE64FD252 Q30575300-477A188F-CE2F-4175-92F5-E123ABBB206E Q33686550-73A17E49-8062-4CAB-A134-C6C74F386C55 Q33744838-C25247BC-0E2C-4CEA-9CBD-A6FD9FEEB74D Q33852213-5397124A-0838-4CD1-905F-0BF294BD6A5E Q34037772-5E13D040-ECD8-497D-B1D3-8194B0503F00 Q35112759-46CEBF07-166C-44FC-BBF4-C2D831B24D02 Q35164047-65BF44D3-A681-4295-87B3-3A0DAC58D33A Q35561941-A5C06BB7-6154-4DB6-9A80-4F755E238CA5 Q35593900-C620976A-0799-43E4-B5BB-62F874CD24BE Q35677091-07DCCB3D-E4DA-4756-B9DD-BB0A0795F5CD Q35847041-1A2A64AF-7E9C-43C1-AA3A-12A4CBE020E3 Q35993403-BBFD0532-DDFE-47CD-B8B8-0EA10FCB2909 Q36069797-96633A8D-5CF3-4F39-AA56-9A4B4C9295CA Q36154554-63264FFC-5694-41F1-8AAA-FCEA01832EC8 Q36203976-8A0F68C1-3122-48CF-9785-AF89C7EA601C Q36461096-A00AD834-A8E0-4E27-A5B9-DB3E1AC9BBD5 Q38196753-116B6A0C-DB11-4C8D-B546-A69B459373B2 Q38833562-BDFEB525-55B1-4D2B-BFDF-2105BA2708D6 Q39165652-963A1E56-4DAD-47E9-960B-4562D0B63861 Q39603238-40D90134-3ACA-4582-93FB-D9A9F9857F69 Q39632617-8936008B-3239-4E89-AFC5-E3361E469698 Q39750492-F272570F-85AB-4AE2-A4CE-B3862B40BE91 Q40428494-53CA3665-0733-4AB6-9709-1CE756CAE648 Q40466820-4428AF50-1294-46A0-8411-84DB097446AF Q40475133-5B7B999E-DE90-47D0-A145-1D6857696ECC Q42115221-83611C03-A2CF-4584-B950-22805C392DBF Q42180745-C9BF00E2-5EAF-4ED6-801F-B3B6C879588F Q42204462-0DDEB067-7577-45E7-AF4D-068688B1BECF Q42235792-01E84885-8481-4BCC-AFA9-91DBCC1698EB Q42734294-AB2199AD-B055-475C-B4DD-A545CFAFF22E Q43138020-2F62F116-46EF-4A96-B50E-42ECF9C7B01B Q46613089-36DD183F-675D-48AE-9AB3-AAFA78285DC9 Q46786508-C52871B8-F6C3-45B9-86D8-035F0A469CD7 Q46850803-E6C0A92A-DF3D-4247-A79F-F6DA231F1DF1 Q46872767-79738CB3-4966-4153-9AE3-2BC707F60C1E Q47216607-088329EF-17B5-4C12-8ADB-AAA775BA3EDB

P2860

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

http://www.wikidata.org/entity/Q33181556

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

@ast

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

@en

type

label

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

@ast

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

@en

prefLabel

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

@ast

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

@en

P1433

Q33181556-0435C0B7-3FAC-4271-BF9D-2C5B7282D5B0

P1476

Q33181556-FF9FF04F-4B4B-4C47-8209-AA93EA60A852

P2093

Q33181556-26CA0F64-1880-4064-B19D-DE6DF3159DA0

Q33181556-6913430D-8C14-4DAD-B2FB-4ACF2B1678EB

Q33181556-84D6205C-7848-4D4C-BDA5-3BF0588263A6

Q33181556-930E964C-7959-434A-A2C9-A7F9EBF9BE0C

Q33181556-CBECD47F-641E-4D8C-B719-AA87AFDDCA19

Q33181556-D786758A-C47F-42B0-90A0-07B31A36EEAF

Q33181556-FB158783-51A4-4DFA-B14D-75F927CA1E53

P2860

Q33181556-0B21615E-4672-4A0A-90B1-0045DD0A5F09

Q33181556-0D84B0A8-548F-4061-9671-BA544BCBA107

Q33181556-18F11392-2349-430B-84B3-F4B7720BA0DC

Q33181556-1B4E2AE1-9E70-4BAC-B720-164226A685E4

Q33181556-347A44A8-5111-470D-945C-83224C7DD902

Q33181556-3946ED41-E900-4F0D-9A1F-6B6C1F956A80

Q33181556-4357E6C7-3F77-40AB-AC96-011FEA5E36F6

Q33181556-45897068-40A6-4F36-BD97-2E063F383266

Q33181556-46D18B64-3EAB-4771-BB14-0D830988C216

Q33181556-5FACC00A-8BF4-47EF-A1F8-74FAC590108B

P304

Q33181556-9A53B938-584A-4ADD-B5DA-8EE02F7CED3A

P31

Q33181556-EA421338-CB7F-420A-8E47-F3F07CEB4A93

P356

Q33181556-8E38CC82-11BF-42E7-BE4C-41E4A3ADA22D

P433

Q33181556-94A44F27-ADCF-4F30-8FB8-BDC930D30035

P478

Q33181556-1E291E08-4849-45C5-AB1D-AB560341C1A4

P50

Q33181556-8A008B89-8D7F-4CA5-A9CC-35378F09C143

P577

Q33181556-6FC7E54C-41A2-4A4C-B675-3E33BAA11123

P5875

Q33181556-BE67156B-CE0E-4BB8-862A-AD3AE2F5ACFC

P698

Q33181556-C9447BD1-AC62-416C-BF7F-F705A2DEF12F

P921

Q33181556-CCBCDC91-3CF5-4C1D-B511-3C2FDFA01AF6

P356

P1433

Journal of Neuropathology & Experimental Neurology

P1476

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

@en

P2093

Bucala R

http://www.w3.org/2001/XMLSchema#string

Kameda Y

http://www.w3.org/2001/XMLSchema#string

Makita Z

http://www.w3.org/2001/XMLSchema#string

Ohkubo T

http://www.w3.org/2001/XMLSchema#string

Suzuki T

http://www.w3.org/2001/XMLSchema#string

Takeuchi M

http://www.w3.org/2001/XMLSchema#string

Yamazaki M

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase

N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

Type 2 diabetes mellitus, cognitive impairment and dementia.

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose.

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.

P304

1094-1105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/59.12.1094

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12190151

http://www.w3.org/2001/XMLSchema#string

P698

11138929

http://www.w3.org/2001/XMLSchema#string

P921